News Archives
The Partnership for Safe Medicines has been publishing information about the counterfeit drug problem around the world for more than a decade. With experts leading the organization and a committed and passionate set of writers and editors, our content is more in-depth than many other sources, which simply copy links to the news from other websites.
On September 30th, the Public Health Department of Santa Clara County, California updated a public health warning they had issued September 10th about deadly counterfeit 30mg oxycodone pills. The initial warning described “tablets visually appear to be the pharmaceutically manufactured version—they are circular in shape, light blue to light green in color, and have an ‘M’ inside a square stamped on one side and a ‘30’ stamped on the other side. Numerous fatal overdoses have been tied to these tablets, with a strong uptick in fatal overdoses in August 2019.”
This editorial by Ryan Costello was published in The Philadelphia Enquirer on October 9, 2019. Mr. Costello is a former U.S. Congressman (PA-06), and is now a public policy consultant.
This editorial by Dr. Kenneth E. Thorpe was published in Town Hall on October 8, 2019. Dr. Thorpe is a professor of health policy at Emory University and chairman of the Partnership to Fight Chronic Disease.
32-year-old Grand Junction resident Ashley Romero was the cherished eldest daughter of her close-knit Colorado family. With her warm heart and brilliant, 1,000 watt smile, she made friends everywhere she went. Ashley died on June 11, 2018, after taking half of an oxycodone pill. The pill was fake and actually made with fentanyl.
In a new series highlighting the good works done by our member organizations for their own causes, PSM spoke with Dr. Rich Sagall about NeedyMeds, the nonprofit he founded to Americans who are struggling to pay for their medications and other healthcare costs…
On September 24, 2019, the Partnership for Safe Medicines and 19 partner organizations held two congressional briefings about the real dangers counterfeit drugs pose to Americans, offering a clear picture of why importation cannot solve the problem of high drug prices in the U.S.:
Canada does not have enough prescription drugs to share with U.S.patients, and organized crime is poised to expand the counterfeit drug trade into the U.S. to bridge the gap without regard for the health and safety of U.S. residents. “The money to be made is far too great to worry about human life.”
A Coral Gables, Florida ophthalmologist at the Beautiful Vision Clinic is being investigated for importing counterfeit Botox from China to use on patients. On September 11, 2019, investigators raided the office of Dr. Francesann Ford and seized boxes of Botox that they allege are counterfeits imported from China.
Two new studies recently published in Canadian Health Policy each reached the same conclusion: legalizing drug importation in the U.S. would cause catastrophic damage to the Canadian drug supply…
This editorial by C. Michael White was published in The Conversation on September 27, 2019. White is a professor and head of the Department of Pharmacy Practice for the University of Connecticut.
On Tuesday, September 24, 2019, counterfeit medication victims and their families, American and Canadian patient groups, local and federal law enforcement, and other experts in the fight against counterfeit medicines gathered in Washington, D.C. to discuss how importation proposals threaten to trigger drug shortages in Canada while wreaking havoc on medication safety for U.S. patients.